Adicet Bio (ACET)

Adicet Bio (ACET) Stock Price & Analysis


ACET Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.61 - $21.87
Previous Close$5.35
Average Volume (3M)469.88K
Market Cap
Enterprise Value$21.68M
Total Cash (Recent Filing)$231.64M
Total Debt (Recent Filing)$23.50M
Price to Earnings (P/E)-2.1
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.53
Shares Outstanding19,589,828
10 Day Avg. Volume357,288
30 Day Avg. Volume469,877
Standard Deviation0.27
Financial Highlights & Ratios
Price to Book (P/B)0.99
Price to Sales (P/S)585.51
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue121.12
Enterprise Value/Gross Profit0.87
Enterprise Value/Ebitda-0.19
Price Target Upside348.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Adicet Bio’s price range in the past 12 months?
Adicet Bio lowest stock price was $4.61 and its highest was $21.87 in the past 12 months.
    What is Adicet Bio’s market cap?
    Currently, no data Available
    When is Adicet Bio’s upcoming earnings report date?
    Adicet Bio’s upcoming earnings report date is Aug 10, 2023 which is in 66 days.
      How were Adicet Bio’s earnings last quarter?
      Adicet Bio released its earnings results on May 09, 2023. The company reported -$0.72 earnings per share for the quarter, missing the consensus estimate of -$0.576 by -$0.144.
        Is Adicet Bio overvalued?
        According to Wall Street analysts Adicet Bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Adicet Bio pay dividends?
          Adicet Bio does not currently pay dividends.
          What is Adicet Bio’s EPS estimate?
          Adicet Bio’s EPS estimate is -$0.43.
            How many shares outstanding does Adicet Bio have?
            Adicet Bio has 42,957,584 shares outstanding.
              What happened to Adicet Bio’s price movement after its last earnings report?
              Adicet Bio reported an EPS of -$0.72 in its last earnings report, missing expectations of -$0.576. Following the earnings report the stock price went up 2.972%.
                Which hedge fund is a major shareholder of Adicet Bio?
                Among the largest hedge funds holding Adicet Bio’s share is RA Capital Management. It holds Adicet Bio’s shares valued at N/A.


                  Adicet Bio Stock Smart Score

                  The Adicet Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Adicet Bio

                  resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.


                  Top 5 ETFs holding ACET

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  iShares Russell 3000 ETF
                  iShares U.S. Tech Breakthrough Multisector ETF
                  Up to five ETFs with an Outperform Smart Score that hold ACET. The ETFs are listed according to market value of ACET within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bioxcel Therapeutics
                  Corbus Pharmaceuticals
                  Eton Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis